Updated flu and COVID vaccines expected this autumn amid federal delay but insurance coverage reassures families

Despite federal recommendations still pending, experts confirm that updated flu and COVID vaccines will be available this autumn, with insurers covering the shots amid ongoing changes to vaccine guidance and the first mRNA flu vaccine approved for select age groups.

Infectious disease specialists say updated flu and COVID vaccines should be on hand this autumn, even as federal recommendations remain stalled. The practical message for families is that shots are still expected to be available, and insurers have signalled they will cover them this season, but that reassurance is coming from clinicians and health plans rather than from a new federal advisory decision.

According to reporting from CIDRAP News at the University of Minnesota, the Food and Drug Administration has already set the vaccine composition for the season, which means manufacturers have been producing doses on schedule. The missing step is guidance from the Centres for Disease Control and Prevention’s Advisory Committee on Immunisation Practices, which has not yet issued recommendations for either vaccine. In the meantime, major medical groups, including the American Academy of Paediatrics, the American Academy of Family Physicians and the American College of Physicians, are still advising routine vaccination.

The CDC says annual flu shots are recommended for everyone aged 6 months and older because flu viruses change from season to season. Its current 2026-2027 guidance also says COVID vaccination is recommended for adults 65 and older, while people aged 6 months to 64 years should make an individual decision with a clinician, with extra attention to those at higher risk of severe illness. That keeps the core public health message intact, even if the usual federal recommendation process has been delayed.

One development this season is the first mRNA flu vaccine, mFLUSIVA, which the FDA approved in early August for adults aged 50 to 64. The agency says the shot is intended to protect against influenza A and B strains included in the vaccine. For families, the key detail is that approval does not automatically mean broad pharmacy availability, and specialists say anyone particularly interested in the new product may need to ask for it by name.

Experts also caution older adults not to wait for the new mRNA option. The FDA approval does not cover people 65 and older, and the CDC continues to prefer enhanced flu vaccines for that age group, such as high-dose, adjuvanted or recombinant products. On the COVID side, current CDC guidance still supports vaccination for older adults and for younger people who are at increased risk, which means the timing of the shot matters more than chasing a specific brand.

For households, the safest approach is to check coverage with the health plan directly rather than assume it. Families using the Vaccines for Children programme should confirm details with a paediatrician or local health department, while uninsured adults can contact a county health department or federally qualified health centre about low-cost options. The broader picture is unchanged: both viruses continue to mutate, protection fades over time, and annual vaccination remains the main way to reduce the risk of severe illness, hospital care and death.